Science | ABNewswire

TIGIT Inhibitor Clinical Trial Pipeline Gains Momentum: 14+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “TIGIT Inhibitor Pipeline Insight 2026” report provides comprehensive insights about 14+ companies and 18+ pipeline drugs in TIGIT Inhibitor pipeline landscape. It covers the TIGIT Inhibitor Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

GROWNSY Announces Big Savings for Amazon Big Spring Sale 2026

New York – GROWNSY, a baby care brand that empowers modern families by creating ingenious, all-in-one parenting solutions, today announced exclusive deals on its most popular products during the Amazon Big Spring Sale, taking place March 25–31, 2026. Shoppers can save … Continue reading →

SHEYERA Unveils MS500, A Highly Anticipated New Release in Shockwave Therapy

New York – As non-invasive musculoskeletal care continues to gain attention in the U.S.the launch of a new shockwave therapy system by SHEYERA comes at a time when shockwave treatment is increasingly being discussed in relation to chronic soft-tissue conditions … Continue reading →

PI3K Inhibitor Treatment Pipeline Shows Strong Momentum as 20+ Pharma Companies in the Race | DelveInsight

DelveInsight’s, “PI3K Inhibitor Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in PI3K Inhibitor pipeline landscape. It covers the PI3K Inhibitor pipeline drug profiles, including PI3K Inhibitor clinical and nonclinical stage products. It also … Continue reading →

ALK Inhibitors Clinical Trial Pipeline Expands as 15+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “ALK Inhibitors Pipeline Insight 2026” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the ALK Inhibitors pipeline landscape. It covers the ALK Inhibitors Pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

SYK Inhibitors Clinical Trial Pipeline Shows Potential with Active Contributions from 10+ Key Companies | DelveInsight

DelveInsight’s, “Spleen Tyrosine Kinase (SYK) Inhibitors Pipeline Insight, 2026” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Spleen Tyrosine Kinase (SYK) Inhibitors pipeline landscape. It covers the SYK Inhibitor pipeline drug profiles, including clinical and nonclinical … Continue reading →

PARP Inhibitors Clinical Trial Pipeline Accelerates as 30+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s “PARP inhibitor Pipeline Insights 2026” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in the PARP inhibitor pipeline landscape. It covers the PARP inhibitor pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

NLRP3 Protein Inhibitors Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “NLRP3 Protein Inhibitors Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in the NLRP3 Protein Inhibitors pipeline landscape. It covers the NLRP3 Protein Inhibitors Pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Ecosense Expands Library Lending Program to Alaska, Bringing Critical Radon Detection Access to Remote and Rural Communities

San Jose, Calif. – March 26, 2026 – Ecosense®, a global leader in radon detection and monitoring technology, today announced the expansion of the Ecosense Library Lending Program into Alaska, improving access to professional-grade radon detectors for residents across the … Continue reading →

SCOPE X Expands the SCOPE 365 Portfolio with a Dedicated Forum for Data Strategies and AI in Clinical Research

SCOPE 365 expands its portfolio with SCOPE X: Data Strategies & AI Innovation in Clinical Research, taking place May 18–19, 2026, in Boston. This executive forum moves beyond surface-level trends to provide deep dives into AI applications and advanced data … Continue reading →

Thursday - April 02, 2026

Category Archives: Science